Publication | Open Access

TP53 or CDKN2A/B covariation in ALK/RET/ROS1-rearranged NSCLC is associated with a high TMB, tumor immunosuppressive microenvironment and poor prognosis

OncologyMedicineImmunologyPathologyHigh TmbPoor PrognosisTumor SuppressorCancer BiologyCdkn2a/b CovariationTumor MicroenvironmentTumor Biology